Compliance to pharmacological therapy of COPD patients with skeletal muscle dysfunction

dc.contributor.author	Poberezhets, V.
dc.contributor.author	Demchuk, A.
dc.contributor.author	Mostovoy, Y.
dc.date.accessioned	2025-03-23T15:05:08Z
dc.date.available	2025-03-23T15:05:08Z
dc.date.issued	2022
dc.identifier.citation	Poberezhets V. Compliance to pharmacological therapy of COPD patients with skeletal muscle dysfunction / V. Poberezhets, A. Demchuk, Y. Mostovoy. - EUROPEAN RESPIRATORY JOURNAL. – 2022. – № 60(suppl 66). – P. 3992.	uk_UA
dc.identifier.issn	1399-3003
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/8778
dc.description.abstract	COPD patients with stable physical performance, less intensive COPD symptoms and absence of skeletal muscle dysfunction are more likely to refuse from using COPD therapy. Adherence to the usage of triple therapy increases with the deterioration of bronchial obstruction and development of skeletal muscle dysfunction.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	European Respiratory Journal	uk_UA
dc.subject	compliance	uk_UA
dc.subject	pharmacological therapy	uk_UA
dc.subject	COPD	uk_UA
dc.subject	skeletal muscle dysfunction.	uk_UA
dc.title	Compliance to pharmacological therapy of COPD patients with skeletal muscle dysfunction	uk_UA
dc.type	Thesis	uk_UA